Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Shares Climb Nearly 10 Percent to Lead BCW Index

Bruker Daltonics shares rose 9.89 percent for the five-day trading period ended Tuesday, capping off a week in which the firm launched a number of new products at Pittcon (see table in feature). Stratagene shares climbed 5.59 percent during the week, while Fisher Scientific shares rose 4.89 percent.

Eleven of the 16 firms in the BCW Index gained ground during the tracking period as the Index rose 1.28 percent. In comparison, the Dow Jones Industrial Average rose 1.55 percent, the Nasdaq climbed 1.21 percent, and the Nasdaq Biotech Index increased 1.39 percent.

BioCommerce Week Index of Diversified Molecular Biology Tool Companies
Company
Ticker
Current Price
(March 14, 2006)
Last Price
(March 7, 2006)
% change
Agilent
A
36.84
36.35
1.35
Applied Biosystems
ABI
27.79
27.7
0.32
Beckman
BEC
52.9
53.12
-0.41
Bio-Rad
BIO
59.08
59.62
-0.91
Bruker
BRKR
4.89
4.45
9.89
Fisher Scientific
FSH
70.2
66.93
4.89
GE
GE
33.78
33.15
1.90
Harvard Bio
HBIO
4.48
4.55
-1.54
Invitrogen
IVGN
70.87
71.34
-0.66
Molecular Devices
MDCC
31.6
31.36
0.77
PerkinElmer
PKI
23.56
23.2
1.55
Qiagen
QGEN
14.85
14.86
-0.07
Sigma
SIAL
64.19
63.67
0.82
Stratagene
STGN
10.39
9.84
5.59
Thermo
TMO
35.51
34.88
1.81
Waters
WAT
43.27
41.77
3.59
BCW Index Average
36.51
36.05
1.28
The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.